Theriva Biologics, Inc. (TOVX)

NYSEAMERICAN: TOVX · IEX Real-Time Price · USD

0.418

+0.012 (2.96%)

At close: May 2, 2024, 4:00 PM

0.420

+0.002 (0.48%)

Pre-market: May 3, 2024, 7:08 AM EDT

Theriva Biologics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2005
Net Income	-18.35	-20.03	-23.19	-12.56	-16.08	-25.29	-22.14	-27.26	-43.74	-19.78	Upgrade
Depreciation & Amortization	0.52	0.27	0.09	0.2	0.24	0.27	0.25	0.16	0.07	0.02	Upgrade
Share-Based Compensation	0.55	0.48	0.42	0.35	0.34	2.07	3.41	4.01	7.55	2.46	Upgrade
Other Operating Activities	-1.72	-0.14	0.87	-2.68	0.85	-6.26	-8.68	-4.81	-2.77	1.23	Upgrade
Operating Cash Flow	-19	-19.08	-12.89	-12.17	-13.87	-17.28	-20.2	-27.9	-38.89	-16.08	Upgrade
Capital Expenditures	-0.2	-0.12	-0.01	-0.01	0	-0.01	-0.21	-0.57	-0.5	-0.05	Upgrade
Acquisitions	0	-4.28	0	0	0	0	0	0	0	0	Upgrade
Investing Cash Flow	-0.2	-4.4	-0.01	-0.01	0	-0.01	-0.21	-0.57	-0.5	-0.05	Upgrade
Share Issuance / Repurchase	2.22	-0.29	74	3.36	0	29.09	6.52	27.32	46.04	20.67	Upgrade
Debt Issued / Paid	-0.08	-1.38	0	0	0	0	0	0	0	0	Upgrade
Other Financing Activities	-1.52	-0.27	-	-	-	-	11.95	-0.62	-3.36	-1.65	Upgrade
Financing Cash Flow	0.63	-1.93	74	3.36	0	29.09	18.48	26.71	42.68	19.03	Upgrade
Exchange Rate Effect	-0.03	-0.03	0	0	0	0	0	0	0	0	Upgrade
Net Cash Flow	-18.61	-25.41	61.1	-8.82	-13.87	11.8	-1.94	-1.76	3.29	2.9	Upgrade
Free Cash Flow	-19.2	-19.2	-12.9	-12.18	-13.87	-17.29	-20.42	-28.47	-39.39	-16.13	Upgrade
Free Cash Flow Per Share	-1.19	-1.25	-1.06	-6.41	-8.44	-27.74	-57.46	-105.68	-170.83	-91.12	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).